Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp477 | Other diseases of bone and mineral metabolism | ECTS2013

A OPTN variant (rs1561570) interacts with TNFRSF11A polymorphism (rs1805034) on the clinical phenotype of sporadic Paget's disease of bone

Merlotti Daniela , Gennari Luigi , Gianfrancesco Fernando , Rendina Domenico , Stefano Marco Di , Esposito Teresa , Divisato Giuseppina , Morello Giovanna , Muscariello Riccardo , Isaia Giancarlo , Strazzullo Pasquale , Nuti Ranuccio

Despite mutations in SQSTM1 gene have been detected in up to 50% of patients with familial Paget’s disease of bone (PDB), their prevalence is low in sporadic PDB, likely due to the presence of additional predisposition genes. Recently, at least seven genes were associated with PDB in genome-wide-association studies, including polymorphic variation in OPTN,encoding for optineurin. In particular, a single OPTN variant (rs1561570) was highly associated with...

ba0005p103 | Cancer and bone: basic, translational and clinical | ECTS2016

Conventional and Pagetic Giant Cell Tumor of bone: distinct clinical features are defined by different genetic background and histological appearance

Divisato Giuseppina , di Carlo Federica Scotto , Esposito Teresa , Pazzaglia Laura , Benassi Maria Serena , Merlotti Daniela , Rendina Domenico , Gennari Luigi , Gianfrancesco Fernando

Conventional Giant Cell Tumor of Bone (GCT) is an aggressive bone tumor characterized by malignant mesenchymal stromal cells, responsible for its unusually high population of multinucleated osteoclast-like giant cells. GCT could arise in bones affected by Paget’s disease of bone (GCT/PDB) with a different clinical profile regarding the age-onset of the neoplasm (30 years vs 50 years) and the skeletal localization (appendicular skeleton vs cranio-facial bones), let hyphote...